ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon Biologics gets global rights for biosimilar Adalimumab
Biocon Biologics has gained complete global rights for Hulio, a biosimilar Adalimumab. This move grants Biocon Biologics full control over manufacturing and commercialization. The company aims to expand affordable access to high-quality biologics for patie
Announcement as on 23 December 2025

Biocon shares in focus ahead of board meeting, fundraising plans
Biocon shares: Biocon’s Board will meet on Saturday, December 6, 2025, to decide on key proposals that could shape its growth and shareholder value. A major agenda item is a potential investment in its unlisted arm, Biocon Biologics either through cash or
Announcement as on 04 December 2025

Biocon's Bengaluru drug manufacturing facility gets 'Voluntary Action Indicated' classification
Biocon Biologics' drug substance facility in Bengaluru has been classified as Voluntary Action Indicated (VAI) by the USFDA. This classification means that while some objectionable conditions were found during the inspection, the agency is not pursuing reg
Announcement as on 27 November 2025

Biocon chief bats for dual-agency model to fast-track drug approvals
Biocon's Kiran Mazumdar-Shaw suggests a new drug approval system. The Indian Council of Medical Research would handle scientific reviews for new drugs and devices. The Central Drugs Standard Control Organisation would then grant final regulatory approval.
Announcement as on 23 November 2025

Biocon in very unique position globally as a biosimilars leader: Kiran Mazumdar-Shaw
Biocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to accelerate growth in the biologics space. The company is uniquely positioned with interchangeable biosimilar insulins and aims to
Announcement as on 21 November 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 391.34
  • 12Day Average: 389.98
  • 20Day Average: 387.02
  • 50Day Average: 379.42
  • 100Day Average: 384.41
  • 150Day Average: 375.11
  • 200Day Average: 372.39

532523 Indicators & signals

Indicator MACD (12,26,9)

388.63, 385.26, 3.51
Indicator MACD is in positive zone

Indicator ADX (14)

0.63, 23.36, 23.07
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Mar 2026 383.20 382.35 to 398.65 -2.42% 1.52 times
12 Thu Mar 2026 392.70 388.80 to 397.30 -0.67% 0.2 times
11 Wed Mar 2026 395.35 394.45 to 402.75 -0.08% 0.37 times
10 Tue Mar 2026 395.65 393.20 to 398.45 1.5% 0.5 times
09 Mon Mar 2026 389.80 379.35 to 390.90 -0.17% 0.17 times
06 Fri Mar 2026 390.45 386.60 to 394.20 1% 0.21 times
05 Thu Mar 2026 386.60 379.15 to 389.00 2.21% 0.44 times
04 Wed Mar 2026 378.25 375.70 to 385.30 -2.6% 6.25 times
02 Mon Mar 2026 388.35 371.00 to 390.20 -0.36% 1.38 times
27 Fri Feb 2026 389.75 389.00 to 396.85 -1.09% 0.1 times
26 Thu Feb 2026 394.05 389.15 to 400.90 -0.4% 0.37 times
25 Wed Feb 2026 395.65 390.30 to 396.85 1.36% 1.18 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top